8-KThe WireRoutine
Shareholder Vote
Filed Jun 10, 2020 · 6y ago · Accession 0001171843-20-004286
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Jun 10, 2020
- Report date
- Jun 9, 2020
- Document
- f8k_061020.htm
- Size
- 199 KB